| Reference |
|---|
Saito T, Ichikawa T, Numakura T, Yamada M, Koarai A, Fujino N, et al. PGC-1α regulates airway epithelial barrier dysfunction induced by house dust mite. Respir Res. 2021;22:63 pubmed publisher |
Oliveira A, Pereira M, Belew A, Ferreira L, Pereira L, Neves E, et al. Gene expression network analyses during infection with virulent and avirulent Trypanosoma cruzi strains unveil a role for fibroblasts in neutrophil recruitment and activation. PLoS Pathog. 2020;16:e1008781 pubmed publisher |
Li T, Zhang Z, Bartolacci J, Dwyer G, Liu Q, Mathews L, et al. Graft IL-33 regulates infiltrating macrophages to protect against chronic rejection. J Clin Invest. 2020;130:5397-5412 pubmed publisher |
Izadi D, Layton T, Williams L, McCann F, Cabrita M, Espirito Santo A, et al. Identification of TNFR2 and IL-33 as therapeutic targets in localized fibrosis. Sci Adv. 2019;5:eaay0370 pubmed publisher |
Kuo C, Chen C, Lo H, Feng C, Wu H, Huang M, et al. Helicobacter pylori Induces IL-33 Production and Recruits ST-2 to Lipid Rafts to Exacerbate Inflammation. Cells. 2019;8: pubmed publisher |
Schaunaman N, Sánchez A, Dimasuay K, Pavelka N, Alam R, Martin R, et al. Interleukin 1 receptor like 1 (IL1RL1) promotes airway bacterial and viral infection and inflammation. Infect Immun. 2019;: pubmed publisher |
Taracanova A, Tsilioni I, Conti P, Norwitz E, Leeman S, Theoharides T. Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin. Proc Natl Acad Sci U S A. 2018;115:E9381-E9390 pubmed publisher |
Hamilton R, Wu Z, Mitra S, Holian A. The Effects of Varying Degree of MWCNT Carboxylation on Bioactivity in Various In Vivo and In Vitro Exposure Models. Int J Mol Sci. 2018;19: pubmed publisher |
Li C, Chen K, Kang H, Yan Y, Liu K, Guo C, et al. Double-stranded RNA released from damaged articular chondrocytes promotes cartilage degeneration via Toll-like receptor 3-interleukin-33 pathway. Cell Death Dis. 2017;8:e3165 pubmed publisher |
Krychtiuk K, Stojkovic S, Lenz M, Brekalo M, Huber K, Wojta J, et al. Predictive value of low interleukin-33 in critically ill patients. Cytokine. 2018;103:109-113 pubmed publisher |
Queiroz G, Costa R, Alcantara Neves N, Nunes de Oliveira Costa G, Barreto M, Carneiro V, et al. IL33 and IL1RL1 variants are associated with asthma and atopy in a Brazilian population. Int J Immunogenet. 2017;44:51-61 pubmed publisher |
Hentschke I, Graser A, Melichar V, Kiefer A, Zimmermann T, Kroß B, et al. IL-33/ST2 immune responses to respiratory bacteria in pediatric asthma. Sci Rep. 2017;7:43426 pubmed publisher |
Neumann K, Karimi K, Meiners J, Voetlause R, Steinmann S, Dammermann W, et al. A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis. J Immunol. 2017;198:128-137 pubmed |
Calvén J, Akbarshahi H, Menzel M, Ayata C, Idzko M, Bjermer L, et al. Rhinoviral stimuli, epithelial factors and ATP signalling contribute to bronchial smooth muscle production of IL-33. J Transl Med. 2015;13:281 pubmed publisher |
Sundnes O, Pietka W, Loos T, Sponheim J, Rankin A, Pflanz S, et al. Epidermal Expression and Regulation of Interleukin-33 during Homeostasis and Inflammation: Strong Species Differences. J Invest Dermatol. 2015;135:1771-1780 pubmed publisher |
Hasan A, Al Ghimlas F, Warsame S, Al Hubail A, Ahmad R, Bennakhi A, et al. IL-33 is negatively associated with the BMI and confers a protective lipid/metabolic profile in non-diabetic but not diabetic subjects. BMC Immunol. 2014;15:19 pubmed publisher |
Lu D, Zhou X, Yao L, Liu C, Ma W, Jin F, et al. Serum soluble ST2 is associated with ER-positive breast cancer. BMC Cancer. 2014;14:198 pubmed publisher |
Willart M, Deswarte K, Pouliot P, Braun H, Beyaert R, Lambrecht B, et al. Interleukin-1? controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J Exp Med. 2012;209:1505-17 pubmed publisher |
Kamekura R, Kojima T, Takano K, Go M, Sawada N, Himi T. The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis. Clin Exp Allergy. 2012;42:218-28 pubmed publisher |
Granne I, Southcombe J, Snider J, Tannetta D, Child T, Redman C, et al. ST2 and IL-33 in pregnancy and pre-eclampsia. PLoS ONE. 2011;6:e24463 pubmed publisher |
Rechardt M, Shiri R, Matikainen S, Viikari Juntura E, Karppinen J, Alenius H. Soluble IL-1RII and IL-18 are associated with incipient upper extremity soft tissue disorders. Cytokine. 2011;54:149-53 pubmed publisher |
Miyagaki T, Sugaya M, Yokobayashi H, Kato T, Ohmatsu H, Fujita H, et al. High levels of soluble ST2 and low levels of IL-33 in sera of patients with HIV infection. J Invest Dermatol. 2011;131:794-6 pubmed publisher |
Mildner M, Storka A, Lichtenauer M, Mlitz V, Ghannadan M, Hoetzenecker K, et al. Primary sources and immunological prerequisites for sST2 secretion in humans. Cardiovasc Res. 2010;87:769-77 pubmed publisher |
Nishida A, Andoh A, Imaeda H, Inatomi O, Shiomi H, Fujiyama Y. Expression of interleukin 1-like cytokine interleukin 33 and its receptor complex (ST2L and IL1RAcP) in human pancreatic myofibroblasts. Gut. 2010;59:531-41 pubmed publisher |
